Belgium· BE-AMP-SAM596622-00
Tektrotyd 20 µg
A 99mtc-technetium hynic-octreotid product containing hynic-[d-phe1,tyr3-octreotide] trifluoroacetate, registered in Belgium by Narodowe Centrum Badań Jądrowych PL. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium hynic-octreotid is registered in 7 of 19 countries.
Countries holding a registration under ATC V09IA07 (99mtc-technetium hynic-octreotid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
99mtc-technetium hynic-octreotid · ATC V09IA07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- HYNIC-[D-Phe1,Tyr3-Octreotide] Trifluoroacetate
- Manufacturer
- Narodowe Centrum Badań Jądrowych PL
- Country
- Belgium (BE)
- ATC code
- V09IA07
- ATC class
- 99mTc-Technetium hynic-octreotid
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IA07
99mtc-technetium hynic-octreotid, as other registers publish it.
- Poland99mTc - TektrotydNarodowe Centrum Badań Jądrowych
- FinlandTektrotydNarodowe Centrum Badán Jadrowych
- DenmarkTektrotydNarodowe Centrum Badan Jadrowych
- PolandTektrotydNarodowe Centrum Badań Jądrowych
- CzechiaTEKTROTYDNarodowe Centrum Badań Jadrowych, Otwock
- NetherlandsTektrotyd 20 microgram kit voor radiofarmaceutisch preparaatNarodowe Centrum Badan Jadrowych
- SwitzerlandTektrotyd, Markierungsbesteckmedeo AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ede154c4-1557-448d-8e4a-cd3a602317c1 GET /v1/drugs/ede154c4-1557-448d-8e4a-cd3a602317c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit for radiopharmaceutical preparation",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tektrotyd 20 µg",
"name_fr": "Tektrotyd 20 µg",
"name_nl": "Tektrotyd 20 µg",
"amp_code": "SAM596622-00",
"strengths": [
"20.0000",
"25.0000",
"10.0000",
"1.2000"
],
"pack_count": 1,
"substances": [
"HYNIC-[D-Phe1,Tyr3-Octreotide] Trifluoroacetate",
"Disodium Hydrogen Phosphate Dodecahydrate",
"Mannitol",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Technetium (99mTc) Hynic-Octreotide",
"authorisation_numbers": [
"BE596622"
]
}See everything about 99mtc-technetium hynic-octreotid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.